Clinical trial No longer in our active list Interventional Ages 20 to 60

Evaluating saliva markers in patients with different periodontal diseases

Official title: Assessment of Saliva Adseverin,1-Alpha Defensin and sRANKL (Soluble RANKL) Levels In Individuals With Different Periodontal Diseases

Run by Izmir Katip Celebi University · NCT06402877 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing if certain saliva markers can help us understand the different types of gum diseases in healthy non-smokers.

More Periodontal Diseases trials

Quick facts

Study typeInterventional
Ages20 Years to 60 Years
SexAll
Enrollment60 (estimated)
SponsorIzmir Katip Celebi University
Academic / other
Locations1 site (İzmir, Çiğli)
Trial IDNCT06402877 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include systemically healthy non-smokers with either periodontitis, gingivitis, or healthy periodontal status.

Probably not a fit

Patients with systemic health issues, smokers, or those on continuous medication may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to detect levels of Adseverin, 1-alpha Defensin, and sRANKL in saliva samples from individuals with varying periodontal health, including those with periodontitis, gingivitis, and healthy gums. A total of 60 systemically healthy non-smokers will participate, providing saliva samples and undergoing full-mouth clinical periodontal assessments. The study will utilize enzyme-linked immunosorbent assay (ELISA) to analyze the correlation between these salivary markers and clinical parameters of periodontal diseases.

Why it matters

Potential benefit: If successful, this study could enhance the understanding of periodontal disease mechanisms and improve diagnostic methods.

How similar studies have gone: While similar studies have explored salivary biomarkers in periodontal diseases, this specific combination of markers is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Systemically healthy (The determination of healthy volunteers will be based on the statements of the patients in the anamnesis. No additional examinations will be made.) At least twenty permanent teeth in the mouth Non-smoker No medication for continuous use Those who have not used antibiotics, anti-inflammatory and systemic corticosteroid drugs in the last 6 months.

Not in pregnancy or lactation period. For the periodontitis group that has not received periodontal treatment in the last 6 months For the periodontitis group; According to the evaluation made in 6 regions of each tooth, individuals with 30% or more bleeding on probing area, at least 2 teeth not adjacent to each quarter jaw with a depth of 5 mm or more and 4 mm or more attachment loss, coronal 1/3 and more on radiography (horizontal and / or vertical) bone loss For the gingivitis group; According to the evaluation made in 6 regions of each tooth, individuals with 10% or more bleeding on probing area, having a probing depth of less than 4mm and no attachment loss For healthy group; According to the evaluation made in 6 regions of each tooth,individuals with less than 10% bleeding on probing area, having a probing depth less than 4mm and no loss of attachment were included in the study.

Exclusion Criteria:

Any oral or systemic disease Regularly using a systemic medication During pregnancy or lactation Received periodontal treatment within the last 6 months. Those who received antibiotic, anti-inflammatory or systemic corticosteroid medication in the last 6 months Smokers are not included in the study

Where it's running

  • Izmir Katip Çelebi University Department of Periodontology
    İzmir, Çiğli, Turkey
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.